Valuation check: TELIF's profit margin is 50.3%, above the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Aug 2026
Trailing 12 months ending Aug 2026
Telescope Innovations (TELIF) currently reports a profit margin of 50.3% as of August 2026. That compares with -17.32% in the prior-year period — up 390.4% year over year. That is above the Healthcare sector average of 17.63%. Use the charts on this page to explore Telescope Innovations's profit margin history and peer comparisons.
Telescope Innovations's profit margin increased from -17.32% to 50.3% — a 390.4% year-over-year increase (period ending August 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Telescope Innovations's profit margin of 50.3% is higher than the Healthcare sector average of 17.63%. That is roughly 185.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Telescope Innovations's current 50.3% should be judged against Healthcare norms (sector average: 17.63%) and against TELIF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 50.3%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Telescope Innovations, and consider following TELIF for alerts when major investors trade the stock.